Wei‐Fu Lv

1.5k total citations
51 papers, 607 citations indexed

About

Wei‐Fu Lv is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Fu Lv has authored 51 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 17 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Fu Lv's work include Liver Disease and Transplantation (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Wei‐Fu Lv is often cited by papers focused on Liver Disease and Transplantation (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). Wei‐Fu Lv collaborates with scholars based in China, Australia and Japan. Wei‐Fu Lv's co-authors include Chunze Zhou, Ping Xu, Wei Wei, Dong Lu, Wenjing Tang, Yusheng He, Yucai Wang, Ruifeng Wang, Wei Jiang and Zhengfeng Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Wei‐Fu Lv

49 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Fu Lv China 14 180 154 131 129 123 51 607
Sith Phongkitkarun Thailand 14 176 1.0× 311 2.0× 120 0.9× 29 0.2× 150 1.2× 37 649
W. Phillip Law Australia 9 150 0.8× 97 0.6× 164 1.3× 136 1.1× 105 0.9× 24 590
Chongtu Yang China 13 360 2.0× 41 0.3× 252 1.9× 157 1.2× 70 0.6× 58 656
Chao‐Wei Lee Taiwan 17 237 1.3× 47 0.3× 190 1.5× 32 0.2× 116 0.9× 79 813
Sangjoon Choi South Korea 15 63 0.3× 79 0.5× 83 0.6× 71 0.6× 157 1.3× 63 681
Qiang Lu China 15 218 1.2× 101 0.7× 200 1.5× 36 0.3× 103 0.8× 54 725
Songjiang Huang China 13 315 1.8× 20 0.1× 216 1.6× 145 1.1× 63 0.5× 42 604
Nitin Shetty India 13 95 0.5× 109 0.7× 62 0.5× 23 0.2× 236 1.9× 73 551
Ivica Grgurević Croatia 16 418 2.3× 70 0.5× 559 4.3× 77 0.6× 43 0.3× 83 880
Ke Lv China 10 73 0.4× 145 0.9× 96 0.7× 24 0.2× 104 0.8× 33 384

Countries citing papers authored by Wei‐Fu Lv

Since Specialization
Citations

This map shows the geographic impact of Wei‐Fu Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Fu Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Fu Lv more than expected).

Fields of papers citing papers by Wei‐Fu Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Fu Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Fu Lv. The network helps show where Wei‐Fu Lv may publish in the future.

Co-authorship network of co-authors of Wei‐Fu Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Fu Lv. A scholar is included among the top collaborators of Wei‐Fu Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Fu Lv. Wei‐Fu Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Wei‐Fu, et al.. (2024). Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma. Journal of Controlled Release. 372. 155–167. 13 indexed citations
2.
3.
Chen, Xiaoqiong, Mingsheng Huang, Xiangrong Yu, et al.. (2024). Hepatic-associated vascular morphological assessment to predict overt hepatic encephalopathy before TIPS: a multicenter study. Hepatology International. 18(4). 1238–1248. 3 indexed citations
4.
5.
Duan, Wenxiu, Lifeng Hang, Yinchu Ma, et al.. (2023). Compartmentalized Nano-MOFs as Co-delivery Systems for Enhanced Antitumor Therapy. ACS Applied Materials & Interfaces. 15(33). 39039–39052. 9 indexed citations
6.
7.
Zhu, Yanhua, Xinfeng Tang, Qian Liu, et al.. (2022). Metallic Carbonitride MXene Based Photonic Hyperthermia for Tumor Therapy. Small. 18(22). e2200646–e2200646. 38 indexed citations
8.
9.
10.
11.
Wu, Yi, Wei Jiang, Shuya Li, et al.. (2021). Nano-metal–organic-frameworks for treating H2O2-Secreting bacteria alleviate pulmonary injury and prevent systemic sepsis. Biomaterials. 279. 121237–121237. 26 indexed citations
12.
Xu, Ping, et al.. (2020). CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity. European Journal of Radiology. 126. 108941–108941. 168 indexed citations
13.
Xu, Ping, et al.. (2020). Differential diagnosis of coronavirus disease 2019 from community-acquired-pneumonia by computed tomography scan and follow-up. Infectious Diseases of Poverty. 9(1). 118–118. 5 indexed citations
14.
Zhou, Chunze, et al.. (2020). Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World Journal of Gastroenterology. 26(24). 3472–3483. 5 indexed citations
15.
Xu, Hao, et al.. (2019). Interventional Treatment Strategy for Primary Budd–Chiari Syndrome with Both Inferior Vena Cava and Hepatic Vein Involvement: Patients from Two Centers in China. CardioVascular and Interventional Radiology. 42(9). 1311–1321. 10 indexed citations
16.
Lü, Jian, Hai‐Dong Zhu, Jin‐He Guo, et al.. (2019). Early Warning Models to Estimate the 30-Day Mortality Risk After Stent Placement for Patients with Malignant Biliary Obstruction. CardioVascular and Interventional Radiology. 42(12). 1751–1759. 3 indexed citations
17.
18.
Dong, Lu, Wei‐Fu Lv, Ming Ni, et al.. (2016). Diagnostic value of multislice computerized tomography angiography for aortic dissection: A comparison with DSA. Experimental and Therapeutic Medicine. 13(2). 405–412. 6 indexed citations
19.
Lv, Wei‐Fu, et al.. (2015). Imaging features of primary hepatic leiomyosarcoma: A case report and review of literature. Oncology Letters. 9(5). 2256–2260. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sith Phongkitkarun Breakdown of academic impact, for papers by W. Phillip Law Breakdown of academic impact, for papers by Chongtu Yang Breakdown of academic impact, for papers by Chao‐Wei Lee Breakdown of academic impact, for papers by Sangjoon Choi Breakdown of academic impact, for papers by Qiang Lu Breakdown of academic impact, for papers by Songjiang Huang Breakdown of academic impact, for papers by Nitin Shetty Breakdown of academic impact, for papers by Ivica Grgurević Breakdown of academic impact, for papers by Ke Lv
Rankless by CCL
2026